Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure

By sjmartinez • September 27, 2022

Banerjee S, Hong J, Umar S. Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure. Front Cardiovasc Med. 2022 Sep 9;9:935423. doi: 10.3389/fcvm.2022.935423. PMID: 36158812; PMCID: PMC9500217.

Tags: Joint Pathway Analysis, monocrotaline, multi-omics, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, right ventricular failure, Sugen/Hypoxia, targeted metabolomics

Assessing the Reliability of Telehealth Geriatric Screening in Older Adults Undergoing Surgery

Canales C, Ivanson HC, Brooks R, Smith J, Boulos NM, Grogan T, Singh S, Sarkisian C, Cannesson M, Whittington R. Assessing the Reliability of Telehealth[...]

A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program

Bailey AV, Frochen S, Kwan L, Siavoshi M, Haroldsen CL, Shelton JB, Rose B, Maxwell KN, Nickols NG, Yamoah K, Rebbeck TR, Schoen MW, Rettig[...]

Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

Lu F, Ahmed AA, Zhang S, Raman VK, Patel SS, Vargas JD, Fonarow GC, Heidenreich PA, Cleland JGF, Anker SD, Böhm M, Metra M, Zile[...]